RIGL vs SHW · P/E 9.1, rev $137.5M vs P/E 29, rev $12.46B
Rigel Pharmaceuticals Inc (RIGL) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Latest reported RIGL revenue for 2026-06-30 was $137.5M. Net income was $25.9M. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
RIGL currently screens at market cap $338.3M and trailing P/E 9.1. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the RIGL and SHW stock pages for the full models.
Not investment advice.